Particle.news
Drug Development Drug Delivery Systems Drug Discovery Antimalarial Drugs Gut Health Non-Psychotropic Compounds Peptides Toxicology Drug Mechanisms Neuropharmacology Drug Interactions Antiviral Agents Analgesics Receptor Biology Pain Research Cannabinoids Cancer Therapies Antimalarial Compounds Active Ingredients Digoxin
Researchers say prior human safety testing for the drug in Parkinson’s and ALS supports moving toward trials even though how the brain clears the proteins remains unclear.
